Skip to content

Randomised control trial of adductor canal block versus intra-articular catheter in knee replacement surgery

In total knee replacement surgery does an adductor canal block or intra-articular catheter with infusions give superior analgesia and range of movement

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12615001139561
Enrollment
100
Registered
2015-10-27
Start date
2016-07-20
Completion date
2017-09-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Participation will involve being randomly assigned to one of two routinely used pain management protocols to provide pain relief in the period immediately after total knee replacement surgery. Participants will be unaware as to which group they are in. A pain specialist doctor and nurse will assess pain control and range of movement of the knee at regular intervals following the surgery. This will assist surgeons and anaesthetists to determine the most effective regimen for future patients.

Interventions

Adductor canal block versus intra-articular catheter for pain relief in total knee replacement surgery. (Both treatments are given in addition to standard anaesthetic care) Group Adductor canal block Ultrasound guided injection into adductor canal to administer block of femoral nerve at this level of 20ml 0.375% ropivacaine with 8mg dexamethasone. Administered once only immediately prior to surgery.

Sponsors

Orthopaedics Western Australia
Lead SponsorOther Collaborative groups

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Undergoing Total knee replacement Able to consent to inclusion in study

Exclusion criteria

Unable to consent to inclusion in study Allergy to trial medications

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026